×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Erick Wayne Devinney

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
AXGNAxogen, Inc.Erick Wayne DevinneyChief Innovation OfficerMar 16, 2025Option/RSU Exercise-32,462-232,873Mar 19, 2025, 05:24 PM
AXGNAxogen, Inc.Erick Wayne DevinneyChief Innovation OfficerMar 19, 2025Sale$17.5015,111264,443217,762Mar 19, 2025, 05:24 PM
AXGNAxogen, Inc.Erick Wayne DevinneyChief Innovation OfficerFeb 28, 2025Option/RSU Exercise-24,799-209,301Mar 04, 2025, 07:22 PM
AXGNAxogen, Inc.Erick Wayne DevinneyChief Innovation OfficerMar 04, 2025Tax Payment (Shares)$18.358,296152,232201,005Mar 04, 2025, 07:22 PM
AXGNAxogen, Inc.Erick Wayne DevinneyChief Innovation OfficerFeb 25, 2025Tax Payment (Shares)$16.5097216,038184,502Feb 26, 2025, 04:23 PM
AXGNAxogen, Inc.Erick Wayne DevinneyChief Innovation OfficerMar 16, 2024Option/RSU Exercise-18,675-180,615Mar 25, 2024, 09:40 PM
AXGNAxogen, Inc.Erick Wayne DevinneyChief Innovation OfficerMar 21, 2024Sale$7.684,57835,159177,474Mar 25, 2024, 09:40 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceOct 13, 2023Disposition to Issuer$4.048643,491113,377Oct 13, 2023, 08:29 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceMar 16, 2023Tax Payment (Shares)$8.272,76922,900112,662Mar 20, 2023, 09:08 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceMar 16, 2023Option/RSU Exercise-8,900-113,596Mar 20, 2023, 09:08 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceDec 27, 2022Tax Payment (Shares)$9.441871,765106,531Dec 29, 2022, 08:56 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceDec 27, 2022Option/RSU Exercise-750-106,718Dec 29, 2022, 08:56 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceDec 27, 2022Tax Payment (Shares)$9.4410,784101,801105,968Dec 28, 2022, 09:34 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceDec 27, 2022Option/RSU Exercise$5.0920,000101,800116,752Dec 28, 2022, 09:34 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceJul 19, 2022Disposition to Issuer$8.404053,40296,752Jul 20, 2022, 04:01 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceMar 16, 2022Option/RSU Exercise-6,000-94,075Mar 18, 2022, 04:03 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceMar 16, 2022Tax Payment (Shares)$7.971,49711,93192,578Mar 18, 2022, 04:03 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceFeb 15, 2022Tax Payment (Shares)$8.423573,00688,075Feb 17, 2022, 04:05 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceDec 27, 2021Tax Payment (Shares)$9.741871,82187,249Dec 29, 2021, 04:17 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceDec 27, 2021Option/RSU Exercise-750-87,436Dec 29, 2021, 04:17 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceDec 20, 2021Option/RSU Exercise-575-86,830Dec 22, 2021, 04:03 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceDec 20, 2021Tax Payment (Shares)$9.241441,33186,686Dec 22, 2021, 04:03 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceDec 15, 2021Tax Payment (Shares)$8.804,17136,70586,255Dec 17, 2021, 04:02 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceDec 15, 2021Option/RSU Exercise$3.6710,00036,70090,426Dec 17, 2021, 04:02 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP Peripheral Nerve ScienceJul 20, 2021Tax Payment (Shares)$19.203927,52680,426Jul 21, 2021, 04:16 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP of Clin. & Trans. SciencesApr 28, 2021Option/RSU Exercise$2.8610,00028,60078,082Apr 30, 2021, 04:10 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP, Clinical&Translational ScFeb 17, 2021Tax Payment (Shares)$18.701,86434,85768,082Feb 18, 2021, 05:26 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP, Clinical&Translational ScDec 29, 2020Sale$17.813716,60863,240Dec 30, 2020, 05:33 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP, Clinical&Translational ScDec 21, 2020Sale$16.421472,41462,111Dec 22, 2020, 03:22 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP, Clinical&Translational ScDec 15, 2020Tax Payment (Shares)$16.504,37372,15561,683Dec 17, 2020, 04:41 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP, Clinical&Translational ScDec 15, 2020Option/RSU Exercise$4.8115,00072,15066,056Dec 17, 2020, 04:41 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP, Clinical&Translational ScApr 28, 2020Option/RSU Exercise$0.272,53068351,056Apr 29, 2020, 05:56 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP, Clinical&Translational ScFeb 18, 2020Tax Payment (Shares)$14.681,84927,14348,526Feb 20, 2020, 01:19 PM
AXGNAxogen, Inc.Erick Wayne DevinneyVP, Clinical&Translational ScDec 18, 2019Tax Payment (Shares)$16.732814,70142,840Dec 20, 2019, 04:27 PM
AXGNAxoGen, Inc.Erick Wayne DevinneyVP, Clinical&Translational ScFeb 15, 2019Tax Payment (Shares)$17.571,49826,32041,971Feb 19, 2019, 01:24 PM
AXGNAxoGen, Inc.Erick Wayne DevinneyVP, Clinical&Translational ScNov 13, 2018Tax Payment (Shares)$33.282,88295,91337,136Nov 15, 2018, 05:18 PM
AXGNAxoGen, Inc.Erick Wayne DevinneyVP, Clinical&Translational ScNov 13, 2018Option/RSU Exercise$2.7235,27495,97440,018Nov 15, 2018, 05:18 PM
AXGNAxoGen, Inc.Erick Wayne DevinneyVP, Clinical&Translational ScMar 14, 2017Option/RSU Exercise$0.275,0181,3555,018Mar 14, 2017, 07:32 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe